Shares of Bristol-Myers Squibb ( BMY) are slipping after Citi analyst Andrew Baum said Pfizer's ( PFE) CEO made it clear to him that the latter has no interest in acquiring the company in the absence of transformational data or a de-rating in the stock.
Bristol-Myers Slips As Citi Says Pfizer Not Interested In Acquisition
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться